Download Supplementary Table Legends

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Polycomb Group Proteins and Cancer wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Biology and consumer behaviour wikipedia , lookup

Primary transcript wikipedia , lookup

Genome (book) wikipedia , lookup

Minimal genome wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Quantitative trait locus wikipedia , lookup

Ridge (biology) wikipedia , lookup

Genome evolution wikipedia , lookup

Oncogenomics wikipedia , lookup

Designer baby wikipedia , lookup

Genomic imprinting wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Microevolution wikipedia , lookup

Gene wikipedia , lookup

Point mutation wikipedia , lookup

Gene expression programming wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Long non-coding RNA wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Epigenetics of human development wikipedia , lookup

Metagenomics wikipedia , lookup

Gene expression profiling wikipedia , lookup

RNA-Seq wikipedia , lookup

Transcript
SUPPLEMENTARY TABLE LEGENDS
Supplementary Table 1. Normalized RPKM expression values and normalized Affymetrix
microarray intensity values for each CRPC sample used for correlation analysis.
Supplementary Table 2. Complete listing of high probability, protein-coding somatic mutations
detected by RNA-seq in CRPC samples. Mutations are classified as either a nonsense or
missense single nucleotide variant (SNV) or as a >1 base insertion (INS) or deletion (DEL). The
gene symbol and Genbank ID is provided for each predicted amino acid change given.
Supplementary Table 3. High confidence putative fusions detected by ChimeraScan (at least
one breakpoint-spanning read) and deFuse (greater than 50% probability score) for each CRPC
sample.
Supplementary Table 4. RPKM values for approximately 45,500 transcripts for all 8 CRPC
samples.
Supplementary Table 5. Top 100 expressed genes as measured by the mean RPKM across all 8
CRPC samples.
Supplementary Table 6. Top 100 expressed genes as measured by the median RPKM across all
8 CRPC samples.
Supplementary Table 7. Novel candidate lncRNAs observed CRPC. List is sorted by average
FPKM for expression of the lncRNA.
Supplementary Table 8. Transcripts, gene names, and gene description for the 1,465 transcripts
with the widest range of expression used for unsupervised clustering of TCGA and CRPC
samples. The average RPKM difference between CRPC and TCGA primary prostate cancers is
shown.
Supplementary Table 9. RNA-SeQC mapping statistics for 8 CRPC RNA-seq samples. For
each sample, the Illumina instrument model, RIN score, type of run, and the number of total and
uniquely-mapping reads is shown. In addition, it is indicated which percentage of quality-filtered
reads mapped to exon, intron or intergenic coordinates, the number of Ensembl genes determined
as expressed, and the percentage of reads mapping to ribosomal RNA.
Supplementary Tables 10-11. Intronic RPB values for genes in CRPC 49 and 66.
Supplementary Table 12. Global analysis of splicing in CRPC. For each CRPC sample, the
number of sequence reads uniquely mapping to an exon-exon splice junction or overlapping an
exon-intron splice boundary is shown. The percentage of unspliced out of the total is indicated.
Supplementary Table 13. Primer sequences for the detection of correctly or incorrectly spliced
portions of AR, KLK2, KLK3, STEAP2, CPSF6, and CDK19.
Supplementary Table 14. Complete results for ChimeraScan on CRPC samples.
Supplementary Table 15. Complete results for deFuse on CRPC samples.